Final hours! Save up to 55% OFF InvestingProCLAIM SALE

'Extreme' vaccine discrimination risks leaving Africa behind - report

Published 12/05/2021, 07:13 PM
Updated 12/05/2021, 07:17 PM
© Reuters. FILE PHOTO: A health worker administers a vaccine during the launch of the South African leg of a global Phase III trial of Sinovac's COVID-19 vaccination of children and adolescents, in Pretoria, South Africa, September 10, 2021. REUTERS/Siphiwe Sibeko

By Tommy Wilkes

LONDON (Reuters) - Africa has little chance of overcoming the COVID-19 pandemic unless 70% of its population is vaccinated by end-2022, yet "extreme vaccine discrimination" is leaving the continent behind, a report published on Monday said.

The discovery of the Omicron variant in southern Africa has heightened claims that low inoculation rates can encourage viral mutations, which can then spread to countries where rates are much higher.

Yet only five of Africa's 54 countries are on track to reach a World Health Organisation target of fully vaccinating 40% of the population by end-2021, the Mo Ibrahim Foundation said in a report on COVID-19 in Africa.

One in 15 Africans has been fully vaccinated, against nearly 70% in the G7 group of richer nations, according to data from the foundation, which was set up by the Sudanese telecoms billionaire to promote better governance and economic development in Africa.

"From early in this crisis, our Foundation and other African voices have been warning that an un-vaccinated Africa could become a perfect incubator for variants," its chair Mo Ibrahim said in a statement.

"The emergence of Omicron reminds us that COVID-19 remains a global threat, and that vaccinating the whole world is the only way forward," he added. "Yet we continue to live with extreme vaccine discrimination, and Africa in particular is being left behind."

Vaccines have been in short supply in Africa after developed countries secured initial orders from pharmaceutical companies and the global vaccine-sharing programme, COVAX, got off to a slow start.

Deliveries of vaccines to Africa have picked up in recent months, but weak healthcare systems and limited infrastructure are holding back rollouts once they arrive, the report said.

There has also been confusion over short expiry dates on donated vaccines, which has led to the destruction of some.

© Reuters. FILE PHOTO: A health worker administers a vaccine during the launch of the South African leg of a global Phase III trial of Sinovac's COVID-19 vaccination of children and adolescents, in Pretoria, South Africa, September 10, 2021. REUTERS/Siphiwe Sibeko

Monday's report said the pandemic had exposed the weakness of African civil registration capacities, with just 10% of African deaths officially registered. Weak systems raised the possibility that vaccination rates were even lower than official statistics showed.

The foundation also said threadbare social safety nets must be strengthened to protect the vulnerable - the average spend in Africa on COVID-19 response measured as a share of GDP excluding healthcare was 2.4%, less than half the global average.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.